Why Was Penicillin Modification Necessary?
Natural penicillins revolutionized medicine, but they had several significant drawbacks. Pharmacologists solved this problem by using 6-aminopenicillanic acid as a backbone and attaching various chemical side chains to its amino group.
This modification pursued three main goals:
- Protection against enzymes. Bacteria learned to produce beta-lactamases (such as penicillinases) that destroy the antibiotic. The new side chains were designed to act as a "shield" for the beta-lactam ring.
- Acid stability. Natural drugs were destroyed by gastric hydrochloric acid. Modification made it possible to create oral forms (per os).
- Spectrum expansion. It was necessary to make the antibiotic effective not only against gram-positive flora but also against gram-negative pathogens.
Classification of Semisynthetic Penicillins
Broadly, these drugs are divided into groups based on their spectrum of activity and ability to resist bacterial enzymes.
- Narrow-spectrum, beta-lactamase-resistant: Isoxazolyl (antistaphylococcal) penicillins. Representatives: oxacillin, nafcillin, cloxacillin, dicloxacillin, flucloxacillin.
- Broad-spectrum, NOT beta-lactamase-resistant: Aminopenicillins. Representatives: ampicillin, amoxicillin.
- Carboxypenicillins: carbenicillin, carfecillin, ticarcillin.
- Ureidopenicillins: azlocillin, piperacillin, mezlocillin.
Antistaphylococcal Penicillins and the MRSA Problem
The main feature of this group is the presence of an isoxazolyl side chain. It sterically blocks the access of staphylococcal beta-lactamases (penicillinases) to the beta-lactam ring of the antibiotic, preventing its hydrolysis.
Key pharmacodynamic nuances:
- These drugs are highly effective against penicillinase-producing staphylococcal strains.
- However, their activity against susceptible flora (which do not produce enzymes) is significantly lower than that of natural penicillins. Therefore, they are prescribed strictly according to indications.
- There are differences within the group: nafcillin is more active than oxacillin against benzylpenicillin-resistant strains, while cloxacillin and flucloxacillin achieve higher serum concentrations.
The MRSA problem: There are hospital-acquired and community-acquired strains of Staphylococcus aureus that have developed resistance to oxacillin and methicillin (MRSA — methicillin-resistant Staphylococcus aureus). Methicillin is unique because it targets only one transpeptidase in S. aureus. In infections caused by MRSA, penicillins are ineffective — vancomycin or linezolid become the drugs of choice.
Aminopenicillins: Ampicillin vs. Amoxicillin
Aminopenicillins are distinguished by an expanded spectrum of activity. The presence of a positively charged amino group in the side chain helps them penetrate through porin channels in the outer membrane of gram-negative bacteria (E. coli, Salmonella, Shigella, Haemophilus influenzae).
Important: this amino group does not protect the drug from beta-lactamases. Aminopenicillins are hydrolyzed by all types of these enzymes and have absolutely no effect on Pseudomonas aeruginosa, Klebsiella, and Serratia species.
Despite belonging to the same group, the two main representatives differ drastically in pharmacokinetics:
| Parameter | Ampicillin | Amoxicillin |
|---|---|---|
| Absorption | Incomplete (30–40%), significantly reduced by food intake. | High (90–95%), independent of food. |
| Routes of administration | Oral, intravenous, intramuscular. | Oral only (per os). |
| Intestinal concentration | High (remains in the lumen due to poor absorption). | Low (almost entirely absorbed in the upper GI tract). |
| Specific indications | Intestinal infections, listeriosis (drug of choice). | ENT infections, H. pylori eradication, endocarditis prophylaxis. |
Protected Penicillins
Because aminopenicillins are vulnerable to bacterial enzymes, a strategy was developed to protect them. The formulation includes not only the antibiotic itself but also a beta-lactamase inhibitor.
The inhibitor takes the brunt of the attack by binding to bacterial enzymes, allowing the antibiotic to reach transpeptidases unhindered and destroy the cell wall. Classic examples of such combinations are amoxicillin + clavulanic acid and ampicillin + sulbactam.